Results 131 to 140 of about 714 (167)
Some of the next articles are maybe not open access.
Transcatheter Tricuspid Valve Repair With the Modified TriClip/MitraClip G4 System.
EuroIntervention, 2021Neil P Fam, Faeez M Ali
exaly +3 more sources
Transcatheter Leaflet Strategies for Tricuspid Regurgitation TriClip and CLASP
Interventional Cardiology Clinics, 2022Since the recognition of the impact of significant tricuspid regurgitation on the clinical course and mortality, intensive efforts have been made in identifying and developing individually suitable and catheter-based therapy strategies to offer those often older and multimorbid patients at high surgical risk safe, feasible, and efficacious treatment ...
Johanna, Vogelhuber +2 more
openaire +2 more sources
His-Bundle Pacing From the Right Atrium: Solving Pacemaker Implantation Challenges Post-TriClip
Journal of Cardiovascular ElectrophysiologyAbstract Introduction This case report highlights the novel role of His‐bundle pacing (HBP) from right atrium, not just for preserving cardiac function, but also for avoiding interference with TriClip devices. Methods and Results A 78‐year‐old female with severe tricuspid regurgitation received two TriClip devices.
Paolo Della Bella +2 more
exaly +2 more sources
TriClip G4: A Game-Changer for Tricuspid Valve Regurgitation Treatment
Current Problems in CardiologyTricuspid valve regurgitation, or TR, is a difficult-to-manage condition. In addition to EVOQUE, percutaneous annuloplasty, and surgical repair, the TriClip G4 system has been added to the interventional therapeutic choices for TR. Recently, the Food and Drug Administration (FDA) approved the use of the TriClip G4 device to treat patients with ...
Muhammad Ammar Samad +2 more
exaly +3 more sources
A Guide for Successful Transcatheter Tricuspid Valve Repair With the Triclip
Catheterization and Cardiovascular InterventionsABSTRACT The use of transcatheter edge‐to‐edge repair (t‐TEER) for tricuspid regurgitation (TR) continues to grow due to its proven clinical results and high safety profile. Yet, because the tricuspid valve is a complex and heterogenous valve, the results of recent landmark t‐TEER trials may be difficult to replicate in daily practice
Craig Basman +2 more
exaly +3 more sources
Percutaneous Tricuspid Valve Repair: The Triclip
Cardiology in ReviewTricuspid regurgitation is an often overlooked, but severe cardiac valvular disease associated with significant morbidity and poor quality of life. Tricuspid valve surgery is the only treatment that prevents progression of the disease but is often complicated or made impossible by perioperative risk factors ...
Madison S, Drogy +2 more
openaire +2 more sources
Transcatheter Intervention for Management of Tricuspid Regurgitation Using TriClip
Cardiology in ReviewSevere tricuspid regurgitation (TR) is an underrated, common pathology that affects over 70 million individuals worldwide. Traditionally, TR has been managed with diuretic therapies without any significant mortality benefit. The underlying cause of TR can be primary, coming from structural issues with tricuspid valve and more commonly secondary ...
Anmol, Sharedalal +4 more
openaire +2 more sources